Delayed resection in the management of non-orbital rhabdomyosarcoma of the head and neck in childhood

被引:0
|
作者
Blatt, J
Snyderman, C
Wollman, MR
Mirro, J
Janecka, IP
Albo, VC
Deutsch, M
Janosky, JE
Wiener, ES
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT OTOLARYNGOL,EYE & EAR HOSP,PITTSBURGH,PA 15260
[2] UNIV PITTSBURGH,SCH MED,DEPT RADIAT ONCOL,PITTSBURGH,PA 15260
[3] UNIV PITTSBURGH,SCH MED,DEPT CLIN EPIDEMIOL & PREVENT MED,PITTSBURGH,PA 15260
[4] CHILDRENS HOSP PITTSBURGH,DEPT PEDIAT SURG,PITTSBURGH,PA 15213
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1997年 / 28卷 / 04期
关键词
rhabdomyosarcoma; cranial base surgery; head and neck;
D O I
10.1002/(SICI)1096-911X(199704)28:4<294::AID-MPO9>3.0.CO;2-D
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This retrospective study was undertaken to evaluate the effect of delayed resection on outcome of head and neck rms in a single institution which has experience in cranial base surgery. Since 1988, patients with primary nonorbital rms of the head and neck following treatment at the Children's Hospital of Pittsburgh, were evaluated by the Department of Otolaryngology, Eye and Ear Hospital at the University of Pittsburgh Medical Center either at the time of presentation or when response to chemotherapy and/or radiation therapy was thought to have been optimized for the possibility of definitive surgery. Medical records of patients who did or did not have delayed surgery were reviewed and compared with respect to demographics, tumor stage, response to therapy, survival, and cosmetic results. Of 16 children diagnosed with non-orbital head and neck rms from 1988-1994 and treated with chemotherapy according to IRS II-IV, 3 had group I or ii disease following extensive surgery at diagnosis. Thirteen had group III or IV disease. Of these, 6 patients had delayed resection and 7 did not. Delayed resection was undertaken 3-12 months (median, 4 months) from diagnosis in 4 children who had a partial response (PR) and 2 children who had stable disease (SD) with chemotherapy and/or radiation. Delayed resection converted all children to complete responses (CR), including one child with clinical SD and one with PR who were found to have no viable tumor at surgery. The overall percentages of CRs for patients with group III or IV disease (documented any time post-diagnosis) were at least as good for patients who had undergone delayed surgery as for those who had not (100% vs. 71%, p = .465). Median survivals for patients with advanced disease were 3 1/2 years and 2 years, respectively (p = .2801). Cosmetic and functional problems attributable to surgery were not severe but included facial asymmetry (n = 4), trismus (n = 1), cranial nerve deficits (n = 1), and abnormal dentition (n = 1). In locally extensive head and neck rms, cranial base surgery should be considered after initial cytoreductive therapy, since it may contribute to achievement of CR and to survival with acceptable morbidity. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:294 / 298
页数:5
相关论文
共 15 条
  • [1] The AMORE protocol as salvage treatment for non-orbital head an neck rhabdomyosarcoma in children
    Buwalda, J
    Blank, LECM
    Schouwenburg, PF
    Copper, MP
    Strackee, SD
    Voûte, PA
    Merks, JHM
    Caron, HN
    EJSO, 2004, 30 (08): : 884 - 892
  • [2] Pediatric non-orbital pseudotumor of the head and neck
    Cherukupally, SR
    Mankarious, LA
    Faquin, W
    Cunningham, MJ
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2003, 67 (06) : 649 - 653
  • [3] Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma
    Clement, S. C.
    Schoot, R. A.
    Slater, O.
    Chisholm, J. C.
    Abela, C.
    Balm, A. J. M.
    van den Brekel, M. W.
    Breunis, W. B.
    Chang, Y. C.
    Fajardo, R. Davila
    Dunaway, D.
    Gajdosova, E.
    Gaze, M. N.
    Gupta, S.
    Hartley, B.
    Kremer, L. C. M.
    van Lennep, M.
    Levitt, G. A.
    Mandeville, H. C.
    Pieters, B. R.
    Saeed, P.
    Smeele, L. E.
    Strackee, S. D.
    Ronckers, C. M.
    Caron, H. N.
    van Santen, H. M.
    Merks, J. H. M.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : 1 - 10
  • [4] Delayed radiation therapy timing and use of intensity-modulated radiation therapy in non-head and neck pediatric rhabdomyosarcoma
    Eaton, Bree R.
    Katzenstein, Howard M.
    Sutter, Anna L.
    Tighiouart, Mourad
    Wasilewski-Masker, Karen
    Qayed, Muna
    George, Bradley
    Olson, Thomas A.
    Esiashvili, Natia
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (01) : 71 - 77
  • [5] THE ROLE OF COMPUTERIZED TOMOGRAPHIC SCANNING IN THE MANAGEMENT OF RHABDOMYOSARCOMA IN NONORBITAL HEAD AND NECK SITES
    NG, YY
    KINGSTON, JE
    PERRY, NM
    REZNEK, RH
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1990, 7 (02) : 149 - 157
  • [6] Management of pediatric head and neck rhabdomyosarcoma: A case-series of 36 patients
    Radzikowska, Joanna
    Kukwa, Wojciech
    Kukwa, Andrzej
    Czarnecka, Anna M.
    Kawecki, Maciej
    Lian, Fei
    Szczylik, Cezary
    Krzeski, Antoni
    ONCOLOGY LETTERS, 2016, 12 (05) : 3555 - 3562
  • [7] Resection and Reconstructive Options in the Management of Dermatofibrosarcoma Protuberans of the Head and Neck
    Akhtar, Aqsa
    Khan, Adeela Hussain
    Rashid, Mamoon
    Eitezaz, Farhan
    Rashid, Haroon Ur
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [8] Surgical management of non melanoma skin cancer of the head and neck
    Kansara, Sagar
    Bell, Diana
    Weber, Randal
    ORAL ONCOLOGY, 2020, 100
  • [9] Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study
    Wenjing Liang
    Langman Li
    Miao Wang
    Yixin Liu
    Ye Qiu
    Boyu Zhang
    Qiuji Wu
    Yongchang Wei
    Clinical and Translational Oncology, 2023, 25 : 1779 - 1792
  • [10] Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study
    Liang, Wenjing
    Li, Langman
    Wang, Miao
    Liu, Yixin
    Qiu, Ye
    Zhang, Boyu
    Wu, Qiuji
    Wei, Yongchang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06) : 1779 - 1792